References
- Mwaniki MK, Atieno M, Lawn JE, et al. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet. 2012;379:445–452.
- Slusher TM, Zamora TG, Appiah D, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open. 2017;1:e000105.
- National Institute for Health and Care Excellence. Jaundice in newborn babies under 28 days [Internet]. [cited 2018 Aug 2]. Available from: https://www.nice.org.uk/guidance/Cg98
- Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance. BMJ. 2010;340:c2409.
- Nagar G, Vandermeer B, Campbell S, et al. Effect of phototherapy on the reliability of transcutaneous bilirubin devices in term and near-term infants: a systematic review and meta-analysis. Neonatology. 2016;109:203–212.
- Rylance S, Yan J, Molyneux E. Can transcutaneous bilirubinometry safely guide phototherapy treatment of neonatal jaundice in Malawi? Paediatr Int Child Health. 2014;34:101–107.
- Nagar G, Vandermeer B, Campbell S, et al. Reliability of transcutaneous bilirubin devices in preterm infants: a systematic review. Pediatrics. 2013;132:871–881.
- Tan KL, Dong F. Transcutaneous bilirubinometry during and after phototherapy. Acta Paediatr. 2003;92:327–331.
- Olusanya BO, Emokpae AA. Use of transcutaneous bilirubin to determine the need for phototherapy in resource-limited settings. Neonatology. 2017;111:324–330.
- Philips BiliChek noninvasive bilirubin assessment tool, 2017 [cited 2018 Jun 19]. Available from: https://philipsproductcontent.blob.core.windows.net/assets/20170616/f722df04b6ce4e7dad79a7940147347a.pdf
- United States Agency for International Development (USAIDS). Haiti health fact sheet. 2017. [cited 2018 Mar 14]. Available from: https://www.usaid.gov/sites/default/files/documents/1862/FINAL_Health_March_2017.pdf
- Drager. Drager JM-103 instructions manual. 2017. [cited 2014 Jan 2]. Available from: https://www.manualslib.com/manual/1302054/Dr-Ger-Jm-103.html
- Gambino SR, Golden WRC, Smith AW. Bilirubin (modified Jendrassik and Grof) – provisional. In: Meites S, editor. Standard methods of clinical chemistry. Vol. 5. New York, NY: Elsevier; 1965. p. 55–64.
- Bland MJ, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307–310.
- StataCorp. Stata statistical software: release 11. College Station, TX: StataCorp LP; 2009.
- Srinivas GL, Cuff CD, Ebeling MD, et al. Transcutaneous bilirubinometry is a reliably conservative method of assessing neonatal jaundice. J Matern Fetal Neonatal Med. 2016;29:2635–2639.
- Grabenhenrich J, Grabenhenrich L, Buhrer C, et al. Transcutaneous bilirubin after phototherapy in term and preterm infants. Pediatrics. 2014;134:1324–1329.
- Jenke A. Transcutaneous bilirubinometry for preterm infants – are there more things to consider? J Pediatr. 2016;168:6–7.
- Mishra S, Chawla D, Agarwal R, et al. Transcutaneous bilirubinometry reduces the need for blood sampling in neonates with visible jaundice. Acta Paediatr. 2009;98:1916–1919.
- von Fricken ME, Weppelmann TA, Eaton WT, et al. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Ouest and Sud-Est departments of Haiti. Acta Trop. 2014;135:62–66.
- Maisels MJ, Ostrea EM Jr, Touch S, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics. 2004;113:1628–1635.